Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Study: No pharmacokinetic drug interactions between memantine and donepezil
March 31st, 2003
Forest Laboratories, Inc., (FRX) announced the results of a new study that show there are no pharmacokinetic interactions between memantine, an investigational drug for Alzheimer disease, and donepezil (Aricept), an approved drug for the treatment of mild-to-moderate Alzheimer disease. Data from the pharmacokinetic study, which was designed to assess for possible drug interactions between memantine and the most commonly prescribed Alzheimer therapy, donepezil, were presented at the American Medical Directors Association (AMDA) annual meeting in Orlando, Florida. Researchers presenting the findings of this trial in 24 healthy subjects reported that...
Source: Pain & Central Nervous System Week (2003-03-31)
|
